By Ben LevisohnUBS analyst Mathhew Roden and team still like biotech stocks, but think it’s time to get more selective, recommending “high quality risk reward names” like Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX), while downgrading Amgen (AMGN) and Regeneron Pharmaceuticals (REGN). They explain why:
Freya Ingrid Morales/Bloomberg News
Although we still think that biotech will continue to outperform the broader markets […]
Biotech Stocks Could Not Hold the Fort -Global Concerns Mount
Pundits and IT Experts Say Cybersecurity Was Not Breached
We see today that even biotech stocks can sell-off on negative macro sentiment. All of the global news compounded by network issues with United Airlines and the NYSE rattled traders and created a bias toward profit taking. Some market experts say this was more […]
At the risk of being considered a Pollyanna or a perma bull, of which I’m neither, I think we are going up hard soon. Now I know said the technicals were in the bulls favor after yesterdays bullish reversal, and they were, but then the most advertised and telegraphed Black Swan happened….China.Greece is still front and center and the NYSE […]
Get the newsLog In or Subscribe to skip3Share This Story!Let friends in your social network know what you are reading aboutNYSE resumes trading after nearly 4 hour haltAll trading on the New York Stock Exchange is halted Wednesday for unknown internal technical reasons – heaping yet another worry onto investors already rattled by global economic concerns.##Sent!A link has been sent […]
Gilead Sciences, Inc. (GILD) Stock Update by Bidness ETC : Wednesday 11:44:23 CTCategories: News, streamGilead Sciences, Inc. (NASDAQ:GILD) has had an unimpressive month so far, which is unusual for a stock that happens to be one of the most traded biotech stocks in the market. The company’s stock has actually traded down 1.67% since the beginning of July, reaching a […]
Biotech stock bubble set for massive implosion: Stocks rose 88% AFTER Fed chair admitted they were overvaluedWednesday, July 8, 2015
By Paul Martinby: J. D. HeyesNaturalNews.comWednesday, July 08, 2015If you’re trying to understand today’s stock market and are having some degree of difficulty, you’re not alone.The markets are confusing enough sometimes for experts, so they can be particularly baffling for laypersons. […]
(NaturalNews) If you’re trying to understand today’s stock market and are having some degree of difficulty, you’re not alone.The markets are confusing enough sometimes for experts, so they can be particularly baffling for laypersons. Still, a few economic basics ought to be pretty simple to understand, right?Wrong – apparently.About a year ago, as documented by the Zero Hedge website, Federal […]
Biotechs rise on Greece ‘No’ Vote!Amazing news, right? I mean, who would think the news out of Greece would push biotech stocks higher?But apparently it did. The Greek people let the world know they ain’t interested in more austerity (not that they really had any). Meanwhile, biotechs were the strongest group of stocks on the market to kick off the […]
Biotechs rise on Greece ‘No’ Vote!Amazing news, right? I mean, who would think the news out of Greece would push biotech stocks higher?But apparently it did. The Greek people let the world know they ain’t interested in more austerity (not that they really had any). Meanwhile, biotechs were the strongest group of stocks on the market to kick off the […]
Of course, all eyes have been on Greece in an ongoing saga that, although critical to the Greeks, is mostly just an annoying distraction for global investors — partly because it has been going on for so many years, with the proverbial can of inevitability continually being kicked down the road, and partly because there can be no winners in […]
